Caspofungin acetate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
    • Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
    • Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
  • Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
  • Empiric treatment of presumed fungal infections in febrile neutropenic patients.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
    • Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
    • Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
  • Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
  • Empiric treatment of presumed fungal infections in febrile neutropenic patients.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: May 1, 2017